Antimicrobial treatment of skin and soft tissue infections.


Journal

Infectious diseases now
ISSN: 2666-9919
Titre abrégé: Infect Dis Now
Pays: France
ID NLM: 101775152

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 11 09 2023
accepted: 14 09 2023
medline: 5 12 2023
pubmed: 22 9 2023
entrez: 21 9 2023
Statut: ppublish

Résumé

Bacterial skin infections are common in children, and frequently do not require systemic antibiotic therapy, particularly for superficial forms. In these cases, washing (with soap and water) and careful rinsing of the lesion are the key points of treatment. A semiotic analysis must precede any therapeutic decision to assess the appropriateness of antibiotic therapy, need for drainage (which may be spontaneous or surgical) and possible existence of symptoms related to toxin production, which are frequent signs of severity. The bacterial species most frequently implicated in children are Staphylococcus aureus and Streptococcus pyogenes. Given the low incidence of methicillin-resistant S. aureus in France (<10%), the first-line antibiotic treatment is amoxicillin-clavulanate, to which an anti-toxin treatment such as clindamycin may be added for patients with overt toxin signs.

Identifiants

pubmed: 37734714
pii: S2666-9919(23)00149-5
doi: 10.1016/j.idnow.2023.104787
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104787

Informations de copyright

Copyright © 2023 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Yves Gillet (Y)

Pediatric Infectious Pathology Group of the French Pediatric Society, Paris, France; Faculty of Medicine Lyon Est - Claude Bernard University, Lyon 1, France; Pediatric Emergency and Intensive Care Service. Hôpital Femme Mère Enfant, Hospices Civils de Lyon, France.

Mathie Lorrot (M)

Pediatric Infectious Pathology Group of the French Pediatric Society, Paris, France; Sorbonne University, France; General Pediatrics, Hôpital Armand-Trousseau, Paris, France.

Philippe Minodier (P)

Pediatric Infectious Pathology Group of the French Pediatric Society, Paris, France; Department of Pediatrics, Hôpital Nord, APHM, Marseille, France.

Antoine Ouziel (A)

Pediatric Infectious Pathology Group of the French Pediatric Society, Paris, France; Pediatric Emergency and Intensive Care Service. Hôpital Femme Mère Enfant, Hospices Civils de Lyon, France.

Hervé Haas (H)

Pediatric Infectious Pathology Group of the French Pediatric Society, Paris, France; Neonatal Pediatrics Department Princess Grace Hospital, Monaco.

Robert Cohen (R)

Pediatric Infectious Pathology Group of the French Pediatric Society, Paris, France; ACTIV, Association Clinique et Thérapeutique Infantile du Val de Marne, Créteil, France; General Pediatrics Department, Centre Hospitalier Intercommunal de Créteil, France; Université Paris Est, Créteil, France. Electronic address: robert.cohen@activ-france.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH